It was reported that an unknown xience v stent was implanted in the left anterior descending artery on (b)(6) 2010.On (b)(6) 2011, the patient had complete atrioventricular block and a pacemaker was implanted.On (b)(6) 2011, the patient had an ischemic stroke which was treated with medication.On (b)(6) 2012, the patient had respiratory failure and cardiac compression was performed by family members.Emergency resuscitation was performed at the hospital, however, the patient died of multiple organ failure.No additional information was provided.
|
(b)(4).There was no reported device malfunction and the product was not returned.The reported patient effects of arrhythmia, cerebrovascular accident, death, ischemia, and respiratory distress are known observed and potential patient effects as listed in the xience v everolimus eluting coronary stent system instructions for use (ifu).Although a conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined, there is no indication of a product quality deficiency with respect to manufacturing, design or labeling.
|